Tesollo kicks off IPO as humanoid hands go global

Tesollo kicks off IPO as humanoid hands go global. The Incheon based developer has officially begun preparations for an initial public offering in the coming year, riding momentum from a completed Series B that backs its global push. The company specializes in high degree of freedom hands, core robotic components, and end effectors meant to boost robot autonomy and human‑robot collaboration, with a roadmap that spans from parallel grippers to more capable end effectors.

The company reports that existing shareholders, including POSCO Technology Investment, KB Investment, and Enlight Ventures, participated in the Series B, with strategic investors from the industrial sector, Daesung Hi-Tech and HL Mando, joining as well. This slate of investors signals strong backing as Tesollo scales from a development and export mindset toward broader manufacturing and market reach. Tesollo has already secured customers across the United States, China, and Japan, and to date has exported its products to 19 countries, with overseas sales now surpassing domestic turnover, marking a clear shift into a global footprint.

Acknowledging the IPO’s role beyond fundraising, CEO Young-Jin Kim framed the offering as a foundation for trust with global customers while accelerating international expansion. “Through our IPO, we aim to establish a corporate foundation that global customers can trust and accelerate our expansion into overseas markets,” he said, underscoring the link between capital markets access and manufacturing scale. The company emphasized its plan to strengthen mass‑production capabilities alongside continued core technology development, positioning Tesollo to compete not just on novelty but on reliable, scalable hardware.

Industry observers are watching Tesollo’s next steps with particular attention to how it translates demonstration progress into real‑world reliability at scale. In March this year, Tesollo showcased the DG-3 three‑fingered gripper and other products at AW 2026, an event that highlighted the company’s move from niche components toward more complete, adaptable end effectors. The DG‑3, alongside existing DG‑2F parallel grippers, illustrates Tesollo’s strategy to offer hands that can pair with a range of humanoid platforms and automation contexts. The demonstrations served to illustrate capabilities in actuation, control, and integration, but the path to production‑ready, fielded solutions will rely on rigorous lifecycle testing and supplier readiness across the supply chain.

From a practitioner standpoint, two to four concrete angles matter most. First, the push to mass production for high‑DOF hands will demand disciplined module standardization, robust testing regimes, and accelerated quality controls to minimize field failures in diverse environments. Second, the multi‑jurisdiction export strategy embodied by customers in the United States, China, and Japan, and the IPO route to fund growth, will intensify focus on regulatory compliance, component sourcing, and geopolitical risk management. Third, Tesollo’s ability to convert a steady stream of global orders into scalable manufacturing throughput will hinge on supplier diversification for actuators, sensors, and control electronics, not just clever mechanical designs. Fourth, while the AW 2026 demonstrations are encouraging, actual deployments in manufacturing, logistics, and service sectors will reveal durability, lifecycle costs, and maintenance economics that go beyond lab performance.

The IPO move, paired with the ongoing product development and international sales trajectory, signals Tesollo’s ambition: turn sophisticated humanoid hands into reliable, mass‑produced end effectors that can operate across industries, at scale, with predictable delivery and service. If the company can bridge the gap between demonstration and industrial deployment, the hands‑of‑the‑future may become a steadier backbone of next‑generation automation.